Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse

J D Nielsen; Meredin Stoltenberg; M Siemsen; A Juul; F Pedersen; J K Madsen

Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse

J D Nielsen, Meredin Stoltenberg, M Siemsen, A Juul, F Pedersen, J K Madsen

Abstract

Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.

Bidragets oversatte titel	Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	152
Udgave nummer	33
Sider (fra-til)	2368-70
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 1990

Citationsformater

@article{2771c7a726e94ecabd7fcf4254c9a507,

title = "Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En sp{\o}rgeskemaunders{\o}gelse",

abstract = "Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.",

author = "Nielsen, {J D} and Meredin Stoltenberg and M Siemsen and A Juul and F Pedersen and Madsen, {J K}",

year = "1990",

language = "Dansk",

volume = "152",

pages = "2368--70",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "33",

}

TY - JOUR

T1 - Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse

AU - Nielsen, J D

AU - Stoltenberg, Meredin

AU - Siemsen, M

AU - Juul, A

AU - Pedersen, F

AU - Madsen, J K

PY - 1990

Y1 - 1990

N2 - Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.

AB - Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 152

SP - 2368

EP - 2370

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 33

ER -

Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse

Abstract

Fingeraftryk

Citationsformater